Gene Information
Gene symbol: FASLG
Gene name: Fas ligand (TNF superfamily, member 6)
HGNC ID: 11936
Synonyms: FasL, CD178
Related Genes
| # | Gene Symbol | Number of hits |
| 1 | BCL2 | 1 hits |
| 2 | BCL2L1 | 1 hits |
| 3 | FAS | 1 hits |
| 4 | HGF | 1 hits |
| 5 | IGF1 | 1 hits |
Related Sentences
| # | PMID | Sentence |
| 1 | 11141501 | Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis. |
| 2 | 11141501 | Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis. |
| 3 | 11141501 | Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis. |
| 4 | 11141501 | Cyclosporin A (CsA) nephropathy is associated with altered expression of apoptosis regulatory genes such as Fas-ligand and Bcl-2 family members in the glomerular, tubulointerstitial, and vascular compartments. |
| 5 | 11141501 | Cyclosporin A (CsA) nephropathy is associated with altered expression of apoptosis regulatory genes such as Fas-ligand and Bcl-2 family members in the glomerular, tubulointerstitial, and vascular compartments. |
| 6 | 11141501 | Cyclosporin A (CsA) nephropathy is associated with altered expression of apoptosis regulatory genes such as Fas-ligand and Bcl-2 family members in the glomerular, tubulointerstitial, and vascular compartments. |
| 7 | 11141501 | Both hepatocyte growth factor (HGF) and insulin-like growth factor (IGF-I) protect against apoptosis, and HGF specifically up-regulates Bcl-xL, a protein that regulates apoptosis. |
| 8 | 11141501 | Both hepatocyte growth factor (HGF) and insulin-like growth factor (IGF-I) protect against apoptosis, and HGF specifically up-regulates Bcl-xL, a protein that regulates apoptosis. |
| 9 | 11141501 | Both hepatocyte growth factor (HGF) and insulin-like growth factor (IGF-I) protect against apoptosis, and HGF specifically up-regulates Bcl-xL, a protein that regulates apoptosis. |
| 10 | 11141501 | We investigated whether Bcl-xL and Fas/Fas-ligand were regulated by CsA in cultured podocytes and whether CsA-induced apoptosis was prevented by HGF or IGF-I. |
| 11 | 11141501 | We investigated whether Bcl-xL and Fas/Fas-ligand were regulated by CsA in cultured podocytes and whether CsA-induced apoptosis was prevented by HGF or IGF-I. |
| 12 | 11141501 | We investigated whether Bcl-xL and Fas/Fas-ligand were regulated by CsA in cultured podocytes and whether CsA-induced apoptosis was prevented by HGF or IGF-I. |
| 13 | 11141501 | A murine podocyte cell line was treated with CsA in the presence or absence of HGF or IGF-I. |
| 14 | 11141501 | A murine podocyte cell line was treated with CsA in the presence or absence of HGF or IGF-I. |
| 15 | 11141501 | A murine podocyte cell line was treated with CsA in the presence or absence of HGF or IGF-I. |
| 16 | 11141501 | Apoptosis was quantitated by ELISA and by flow cytometry; Bcl-xL, Fas, and Fas-ligand were measured by Western blotting. |
| 17 | 11141501 | Apoptosis was quantitated by ELISA and by flow cytometry; Bcl-xL, Fas, and Fas-ligand were measured by Western blotting. |
| 18 | 11141501 | Apoptosis was quantitated by ELISA and by flow cytometry; Bcl-xL, Fas, and Fas-ligand were measured by Western blotting. |
| 19 | 11141501 | Inhibitors of MAP kinase/ERK kinase (MEK)-1 and of phosphatidylinositol 3'-kinase (PI3'-K) were used to determine the signaling pathways involved in Bcl-xL regulation. |
| 20 | 11141501 | Inhibitors of MAP kinase/ERK kinase (MEK)-1 and of phosphatidylinositol 3'-kinase (PI3'-K) were used to determine the signaling pathways involved in Bcl-xL regulation. |
| 21 | 11141501 | Inhibitors of MAP kinase/ERK kinase (MEK)-1 and of phosphatidylinositol 3'-kinase (PI3'-K) were used to determine the signaling pathways involved in Bcl-xL regulation. |
| 22 | 11141501 | HGF, but not IGF-I, prevented apoptosis and restored Bcl-xL levels. |
| 23 | 11141501 | HGF, but not IGF-I, prevented apoptosis and restored Bcl-xL levels. |
| 24 | 11141501 | HGF, but not IGF-I, prevented apoptosis and restored Bcl-xL levels. |
| 25 | 11141501 | The regulation of Bcl-xL by HGF was mediated by the PI3'-K but not by the MEK-1 pathway. |
| 26 | 11141501 | The regulation of Bcl-xL by HGF was mediated by the PI3'-K but not by the MEK-1 pathway. |
| 27 | 11141501 | The regulation of Bcl-xL by HGF was mediated by the PI3'-K but not by the MEK-1 pathway. |
| 28 | 11141501 | Apoptosis was prevented by pretreatment with HGF but not IGF-I. |
| 29 | 11141501 | Apoptosis was prevented by pretreatment with HGF but not IGF-I. |
| 30 | 11141501 | Apoptosis was prevented by pretreatment with HGF but not IGF-I. |